Share this article
Share this article
to reach USD 9.8 billion by 2028, based on a new report by Grand View Research, Inc. The market is expected
to expand at a CAGR of 11.4% from 2021 to 2028. The growth can be primarily attributed to the technological advancements in molecular detection platforms. The technologies such as robotic liquid handling in automated DNA extraction systems, have improved the process flow. Such automation has streamlined all the tasks involved in various processes, such as DNA extraction from samples, serial dilution, and picking the desired gene of interest.
Key suggestions from the report:
The kits and reagents segment accounted for the largest revenue share in 2020 owing to the rising number of research studies focused on understanding rare and common genome-based diseases